AI4L 1.0 uses audit-driven prompting to produce hallucination-free, citation-verified longevity reviews, addressing widespread distrust in AI health advice. Forever Healthy’s AI4L 1.0 promises to re...
Explore how partial reprogramming using Yamanaka factors reverses epigenetic aging, with recent advances in mice and early clinical trials paving the way for rejuvenation therapies. Partial reprogramm...
New research reveals that pulsed electromagnetic fields can activate gene therapy in aged mice, improving survival and reducing aging markers, but ethical questions loom. A groundbreaking study demons...
New research links eusociality to extreme longevity, revealing mechanisms like hyaluronic acid and epigenetic reprogramming that could inspire human anti-aging therapies. Eusocial species live excepti...
The 2025 longevity investment landscape shifts from narrow anti-aging to a full innovation stack, led by cellular reprogramming, brain longevity diagnostics, and platform infrastructure. Investors pou...
Large animals like whales and elephants have evolved superior DNA repair and cancer suppression mechanisms, offering insights for human aging and disease prevention. New studies reveal how massive mam...
A 2023 study in the Journal of Cachexia, Sarcopenia and Muscle finds rapamycin reduces muscle protein synthesis after exercise in older adults, highlighting trade-offs in longevity strategies. Recent ...
Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
Exploring how mild mitochondrial stress through drugs like terbinafine and miglustat extends lifespan, with socioeconomic implications for longevity treatments. New research shows FDA-approved drugs c...
A new study on HMGB1’s Box A domain shows it can create DNA gaps, reversing age-related damage in non-human primates with up to 40% proteomic improvement, highlighting potential gene therapy for...
